GlassScriptPhysician profile
Vadim A Roytenberg
NPI 1073505905
$723.72
in general payments reported to CMS, 2019-2025
16 companies · $114 in 2025
The $114 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $73.44 · 2021: $242 · 2022: $46.06 · 2023: $98.64 · 2024: $150 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $362.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $159.01 | 2020-2025 | Verquvo, Capvaxive |
| Takeda Pharmaceuticals U.S.A., INC. | $82.80 | 2021-2025 | Entyvio |
| Redhill Biopharma INC. | $74.32 | 2021 | |
| Nestle Healthcare Nutrition INC. | $54.54 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.37 | 2020 | |
| Ardelyx, INC. | $53.84 | 2023 | Ibsrela |
| Janssen Biotech, INC. | $37.69 | 2025 | Tremfya |
| Seqirus USA INC | $29.35 | 2023 | Fluad Quadrivalent, Flucelvax Quadrivalent |
| Braintree Laboratories, INC. | $28.71 | 2024 | Suflave |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.89 | 2022 | |
| Csl Behring | $22.62 | 2021 | |
| Qol Medical, LLC | $22.44 | 2021 | |
| Alexion Pharmaceuticals, INC. | $21.17 | 2022 | |
| Vivus LLC | $20.93 | 2024 | Qsymia |
| Althera Pharmaceuticals LLC | $19.48 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $17.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vadim Roytenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.